View from the Top
PROSPERiA’s AI-powered diagnostic tools aim to set the foundation of a preventive healthcare culture in Mexico.
Personalized medicine could be used to treat a disease affecting about 12 percent of the world’s population. But is it cost-effective?
The company faces challenges as more than 60 percent of its products are not healthy with ongoing pressure as obesity and diabetes trends accelerating
UK Ambassador to Mexico Corin Robertson detailed how this pandemic has demonstrated the importance of exchanging knowledge at a global level.
Diabetes remains one of the most costly diseases in Mexico and the problem will only increase as the population in Mexico grows older and older